Tonix Pharmaceuticals Announces Top Line Results From Phase 2 Proof-of-Concept Clinical Study Life Science Investing
Capsugel and Pulmatrix Enter Collaboration to Develop and Manufacture Novel Inhaled Therapeutics Biotech Investing
Celator Pharmaceuticals Phase 3 Trial of VYXEOS™ (CPX-351) Reaches Required Number of Events for Overall Survival Analysis Biotech Investing
DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2016 Financial Results and Corporate Update Life Science Investing
